| Individual Articles - Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: Revised Format
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 358
|
PreScription: Compounding Veterinary Products: Needed but Problematic
Menighan Thomas E
|
Sep/Oct 2010
Pg. 358
|
Home Infusion Accreditation: Another Quality Recognition Branding Tool
Canally Sandra C
|
Sep/Oct 2010
Pg. 360-364
|
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response
Briggs Valerie
|
Sep/Oct 2010
Pg. 366-369
|
Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device
Kennedy Steve, Siefert Lisa Linn, Lange Matt
|
Sep/Oct 2010
Pg. 370-372
|
Bioidentical Hormones in the News
Bramwell Bethany L
|
Sep/Oct 2010
Pg. 374-380
|
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Meadows Richard L, Muller George
|
Sep/Oct 2010
Pg. 382-394
|
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients
Muller George, Case Tyler, Deen Griffin L
|
Sep/Oct 2010
Pg. 395-399
|
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 1
Evans Alex, Haile Michael, Anderson Kim
|
Sep/Oct 2010
Pg. 401-405
|
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1
Dubczak John, Latta Kenneth S, Hedman Hilary, Smith Donald R
|
Sep/Oct 2010
Pg. 407-414
|
Basics of Compounding: Basics of Compounding with Esters
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 416-418
|
Calculations
Stockton Shelly J
|
Sep/Oct 2010
Pg. 419
|
Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 420
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Icy Blue Camphorated Gel
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 422
|
Carvedilol 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 423
|
Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 424
|
Triclosan 0.28% Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 425
|
Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 426
|
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 427
|
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 428
|
Polidocanol 0.5% Wound Spray
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 429
|
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Santoveña A, Llabrés M, Fariña JB
|
Sep/Oct 2010
Pg. 430-435
|
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device
Tsiouris Maria, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min
|
Sep/Oct 2010
Pg. 436-439
|
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board
Pharmacy Compounding Accreditation Board
|
Sep/Oct 2010
Pg. 440-441
|
